Empagliflozin CAS:864070-44-0 Mugadziri wezvigadzirwa

Empagliflozin mushonga mutsva, une simba uye unosarudza weSGLT-2 inhibitor, unovandudza kudzora kweglucose uye hunhu hwe metabolic syndrome mumakonzo ane chirwere cheshuga.Empagliflozin (zita rekutengeserana rekuti Jardiance) inhibitor ye sodium glucose co-transporter-2 (SGLT-2), uye inoita kuti shuga muropa ibudiswe neitsvo uye ibviswe muweti.Empagliflozin inogona kukonzera kushaya mvura mumuviri uye kutungamira kudzikira kweBP, zvichikonzera varwere vane dzungu kana kupera simba uye kudzikira kwekushanda kweitsvo. Njodzi yevarwere vakwegura, kunyanya avo vane dambudziko rekushanda kweitsvo uye diuretics, inoita kunge yakakura.FDA inoda kuti Boehring naEli Lilly vaite zvidzidzo zvina zvepashure pekushambadza: miedzo yakazara yemhedzisiro yemwoyo inoenderera mberi, miedzo ye pharmacokinetics yevana uye pharmacodynamics, miedzo yekuchengetedza vana uye kushanda zvakanaka, bvunzo yechepfu yemushonga (kunyanya mhedzisiro yekushanda kweitsvo, mapfupa nekukura nekukura).